Latest filing published 27 Apr 2022 for SynAct Pharma AB, €53k.
Insider track record
No signal scores available.
BioInvest Aps: trading record in brief
BioInvest Aps is a declared insider of SynAct Pharma AB, with filings sourced from Finansinspektionen. Altogether 2 filings, all relating to 22 April 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 27 April 2022, reports a transaction of €53k in SynAct Pharma AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to BioInvest Aps
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,730 shares@ SEK 63.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0017768963FI:csv-a034bf4a5a3df93233d3
- 3,656,899 shares0Teckningsrätt/UniträttISIN SE0017768955FI:csv-b89321ffff7186c77209
2 of 2 declarations